KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Castle Biosciences (CSTL) over the last 2 years, with Sep 2025 value amounting to $48,000.

  • Castle Biosciences' Other Non Operating Income was N/A to $48,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2020, which is 126.80% down from last year.
  • As of Q3 2025, Castle Biosciences' Other Non Operating Income stood at $48,000, which was up 103.43% from -$1.4 million recorded in Q4 2020.
  • In the past 5 years, Castle Biosciences' Other Non Operating Income ranged from a high of $48,000 in Q3 2025 and a low of $48,000 during Q3 2025.
  • In the last 1 years, Castle Biosciences' Other Non Operating Income had a median value of $48,000 in 2025 and averaged $48,000.